FDA Approves Rezenopy (naloxone hydrochloride) Nasal Spray for the Emergency Treatment of Opioid Overdose

April 19, 2024 -- The U.S. Food and Drug Administration has approved Rezenopy (naloxone hydrochloride) nasal spray 10 mg for the emergency treatmentof known or suspected opioid overdose, as manifested by respiratory and/or central nervous system...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news